Search Results - "Loeschmann, Nadine"
-
1
Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen
Published in Scientific reports (03-02-2015)“…Flubendazole was shown to exert anti-leukaemia and anti-myeloma activity through inhibition of microtubule function. Here, flubendazole was tested for its…”
Get full text
Journal Article -
2
Aurora kinases as targets in drug-resistant neuroblastoma cells
Published in PloS one (30-09-2014)“…Aurora kinase inhibitors displayed activity in pre-clinical neuroblastoma models. Here, we studied the effects of the pan-aurora kinase inhibitor tozasertib…”
Get full text
Journal Article -
3
multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication
Published in Cellular and molecular life sciences : CMLS (01-03-2011)“…Human cytomegalovirus (HCMV) is a major pathogen in immunocompromised individuals. Here, non-toxic concentrations of the anti-cancer kinase inhibitor sorafenib…”
Get full text
Journal Article -
4
Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status
Published in Oncotarget (10-07-2015)“…The PKCβ inhibitor enzastaurin was tested in parental neuroblastoma and rhabdomyosarcoma cell lines, their vincristine-resistant sub-lines, primary…”
Get full text
Journal Article -
5
ABCB1 as predominant resistance mechanism in cells with acquired SNS-032 resistance
Published in Oncotarget (06-09-2016)“…The CDK inhibitor SNS-032 had previously exerted promising anti-neuroblastoma activity via CDK7 and 9 inhibition. ABCB1 expression was identified as major…”
Get full text
Journal Article -
6
The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β
Published in Biochemical pharmacology (15-01-2011)“…Enzastaurin is a selective protein kinase Cβ inhibitor which is shown to have direct antitumor effect as well as suppress glycogen synthase kinase-3β (GSK-3β)…”
Get full text
Journal Article -
7
Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs
Published in Translational oncology (01-12-2013)“…Novel treatment options are needed for the successful therapy of patients with high-risk neuroblastoma. Here, we investigated the cyclin-dependent kinase (CDK)…”
Get full text
Journal Article